Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride

碱式水杨酸铋/甲硝唑/盐酸四环素

Report date: 2024/09/05 17:52:03

Base Information

Drug NameBismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride
Drug Alias NameBismuth Subsalicylate and Metronidazole and Tetracycline Hydrochloride碱式水杨酸铋甲硝唑盐酸四环素Bismuth subcitrate/metronidazole/tetracyclineBismuth subcitrate - tetracycline - metronidazole mixtHelidac
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of ActionProtein biosynthesis inhibitorsDNA synthesis inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsHelicobacter pylori infectionDuodenal Ulcer
Global Approved IndicationsHelicobacter pylori infectionDuodenal Ulcer
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1996/08/15
Country/TerritoryUnited States
CombinationsYes Tetracycline HydrochlorideMetronidazoleBismuth Subsalicylate
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesCasper Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCasper Pharma Llc
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionDuodenal Ulcer

Other Information

ATC CodeA02BD08
Related LinksWikipediaKEGG